Literature DB >> 36267161

Skin reaction to COVID-19 vaccine: A report of 4 cases.

Mariabeatrice Bertolani1, Maria Beatrice de Felici Del Giudice1, Erminia Ridolo2, Francesco Pucciarini2, Claudio Feliciani1, Francesca Satolli1.   

Abstract

Since the beginning of the covid-vaccine campaign, a lot of local and systemic dermatologic reactions happening after the administration of Coronavirus disease 2019 (COVID-19) vaccines have been described, even if their exact biological mechanism is still debated. In this paper we report 4 cases of cutaneous manifestations arose within ten days after the first dose of messenger RNA (mRNA)-based COVID-19 vaccination: one case of giant urticaria, one case of head and neck redness and two cases of Erythema Multiforme (EM). In our experience these reactions were mild, transient and all of them resolved, not recurring after the second dose, so these manifestations shouldn't be considered as an absolute contraindication to the second dose of vaccine, that to date is fundamental. ©Copyright: the Author(s).

Entities:  

Keywords:  COVID-19; Skin reaction; Vaccination

Year:  2022        PMID: 36267161      PMCID: PMC9577375          DOI: 10.4081/dr.2022.9376

Source DB:  PubMed          Journal:  Dermatol Reports        ISSN: 2036-7392


  9 in total

1.  Triggers, clinical manifestations, and management of pediatric erythema multiforme: A systematic review.

Authors:  Samer Zoghaib; Elio Kechichian; Karim Souaid; Boutros Soutou; Josiane Helou; Roland Tomb
Journal:  J Am Acad Dermatol       Date:  2019-07-19       Impact factor: 11.527

2.  Cutaneous adverse reactions after m-RNA COVID-19 vaccine: early reports from Northeast Italy.

Authors:  E Farinazzo; G Ponis; E Zelin; E Errichetti; G Stinco; C Pinzani; A Gambelli; N De Manzini; L Toffoli; A Moret; M Agozzino; C Conforti; N Di Meo; P Schincariol; I Zalaudek
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-06-07       Impact factor: 9.228

3.  Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single centre case series.

Authors:  M Corbeddu; A Diociaiuti; M R Vinci; A Santoro; V Camisa; S Zaffina; M El Hachem
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-04-08       Impact factor: 6.166

4.  Skin manifestations of the BNT162b2 mRNA COVID-19 vaccine in healthcare workers. 'COVID-arm': a clinical and histological characterization.

Authors:  D Fernandez-Nieto; J Hammerle; M Fernandez-Escribano; C M Moreno-Del Real; P Garcia-Abellas; I Carretero-Barrio; E Solano-Solares; B de-la-Hoz-Caballer; J Jimenez-Cauhe; D Ortega-Quijano; M Fernandez-Guarino
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-03-30       Impact factor: 6.166

Review 5.  Current Perspectives on Erythema Multiforme.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

6.  Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to "potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases".

Authors:  Rossella Talotta
Journal:  Clin Immunol       Date:  2021-01-08       Impact factor: 3.969

7.  Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.

Authors:  Devon E McMahon; Erin Amerson; Misha Rosenbach; Jules B Lipoff; Danna Moustafa; Anisha Tyagi; Seemal R Desai; Lars E French; Henry W Lim; Bruce H Thiers; George J Hruza; Kimberly G Blumenthal; Lindy P Fox; Esther E Freeman
Journal:  J Am Acad Dermatol       Date:  2021-04-07       Impact factor: 11.527

8.  Covid-19 vaccine and autoimmunity: Awakening the sleeping dragon.

Authors:  Karolina Akinosoglou; Ilektra Tzivaki; Markos Marangos
Journal:  Clin Immunol       Date:  2021-04-03       Impact factor: 3.969

Review 9.  COVID-19 vaccines: What dermatologists should know?

Authors:  Azin Ayatollahi; Hamed Hosseini; Rojin Firooz; Alireza Firooz
Journal:  Dermatol Ther       Date:  2021-07-13       Impact factor: 3.858

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.